The United States recorded the country’s largest weekly rise in Covid-19 deaths since August, increasing 32% from the previous week to average about 1,500 people per day, according to a Reuters analysis of state and county reports.

The U.S. government will start distributing Regeneron Pharmaceuticals Inc.’s newly authorized Covid-19 antibody combination on Nov. 24, beginning with more than 30,000 treatment courses, a health official said.

It took Oxford University’s brightest minds decades of work to give them the expertise to develop a Covid-19 vaccine.

The United States recorded the country’s 12th million Covid-19 case, even as millions of Americans were expected to travel for the upcoming Thanksgiving holiday, ignoring warnings from health officials about furthering the spread of the infectious disease.

AstraZeneca started late-stage trials of an experimental long-acting monoclonal antibody combination drug the company hopes could be used as a so-called prophylactic to prevent Covid-19 infection in at-risk people for up to 12 months.

People who have had Covid-19 are highly unlikely to contract the disease again for at least six months after their first infection, according to a British study of healthcare workers on the frontline of the fight against the coronavirus pandemic.

Johnson & Johnson was ordered by a New York state judge to pay $120 million in damages to a Brooklyn woman and her husband, after she blamed her cancer on asbestos exposure from using the company’s baby powder.

A new wave of mobile apps that help track exposure to the coronavirus is coming to U.S. states ahead of the holidays as public health officials bet that recently introduced features from Apple Inc. and Alphabet Inc.’s Google will significantly boost adoption and impact.

The number of people hospitalized with Covid-19 in the United States jumped nearly 50% in a 14-day period, straining the nation’s healthcare system and forcing states to impose new restrictions to curb the alarming spread of the coronavirus.

Russia resumed the vaccination of new volunteers in a clinical trial for the country’s flagship Covid-19 Sputnik V vaccine after a short pause, staff at six of 29 trial clinics said, as Moscow moves to accelerate plans to inoculate the population.